<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/comparison-of-gadofosveset-trisodium-and-gadobenate-dimeglumine-during-time-resolved-thoracic-mr-ang/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/comparison-of-gadofosveset-trisodium-and-gadobenate-dimeglumine-during-time-resolved-thoracic-mr-ang/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2010-10-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2010-10-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/comparison-of-gadofosveset-trisodium-and-gadobenate-dimeglumine-during-time-resolved-thoracic-mr-ang/"},"url":"https://clinicaltree.github.io/posts/comparison-of-gadofosveset-trisodium-and-gadobenate-dimeglumine-during-time-resolved-thoracic-mr-ang/"}</script><title>Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1288544400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Oct 31, 2010 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Alex Frydrychowicz MD</a> </em>, <em> <a href="">Maximilian F. Russe</a> </em>, <em> <a href="">Jelena Bock MSc</a> </em>, <em> <a href="">Aurélien F. Stalder PhD</a> </em>, <em> <a href="">Thorsten A. Bley MD</a> </em>, <em> <a href="">Andreas Harloff MD</a> </em>, <em> <a href="">Michael Markl PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1734 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Gadofosveset trisodium is a blood-pool contrast agent (BPA) that shows a less pronounced r1 relaxivity advantage over gadobenate dimeglumine at 3T than at 1.5T. However, there are few data on image quality during first-pass imaging of the thoracic vasculature with gadofosveset trisodium at 3 T. Therefore, it was the aim of this study to compare first-pass imaging characteristics of gadofosveset trisodium to gadobenate dimeglumine during time-resolved contrast-enhanced three-dimensional magnetic resonance angiography (CE MRA) at 3 T.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Twenty volunteers underwent time-resolved CE MRA on a 3 T magnetic resonance (MR) system with a standard eight-channel phased-array surface coil, receiving either gadofosveset trisodium (blood pool agent [BPA], <em>n</em> = 10) or gadobenate dimeglumine (standard contrast agent, [SCA], <em>n</em> = 10). Image quality was assessed by two independent readers using a Likert scale ranging from 0 = poor quality to 3 = excellent quality, and relative signal-to-noise and contrast-to-noise ratios were calculated.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Equally good to excellent first-pass image quality was confirmed for time-resolved CE MRA using BPA and SCA (arteries, 2.8 ± 0.2 and 2.6 ± 0.4; veins, 2.5 ± 0.3 and 2.2 ± 0.4; artifacts, 2.4 ± 0.2 and 2.3 ± 0.1). Signal-to-noise and contrast-to-noise ratios showed nonsignificant differences, except for left subclavian artery values. There was an overall nonsignificant superiority in signal-to-noise and contrast-to-noise ratios for standard contrast agent in arterial values and BPA regarding venous values.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Despite a markedly decreased <em>r</em> 1/ <em>r</em> 2 relaxivity ratio, first-pass imaging characteristics of gadofosveset trisodium and gadobenate dimeglumine are equally well suited for first pass time-resolved CE MRA at 3 T.</p><p>The most widely used gadolinium-based agents for contrast-enhanced magnetic resonance angiography (CE-MRA) have small molecular sizes, resulting in short blood-pool residence times. Gadofosveset trisodium is a gadolinium-based blood-pool contrast agent (BPA) based on a higher albumin-binding capacity and thus a considerably prolonged intravascular residence time. In addition, the multiple paramagnetic ions attached to each macromolecule result in a relatively high T1 relaxivity, as shown by Rohrer et al (at 1.5 T, gadofosveset trisodium <em>r</em> 1 = 19 vs gadobenate dimeglumine <em>r</em> 1 = 6.3 in plasma at 37°C). However, at 3 T, contrast agents show individual field-strength dependencies that result in a less pronounced differences between relaxivities (at 3 T, gadofosveset trisodium <em>r</em> 1 = 9.9 vs gadobenate dimeglumine <em>r</em> 1 = 5.5 in plasma at 37°C) and hence altered <em>r</em> 1/ <em>r</em> 2 ratios .</p><p>Previous studies have focused on the benefits of the longer acquisition window of BPAs that can be exploited for time-intensive high-resolution assessment of arteries and veins at low concentrations at 1.5 T . Preclinical tests of gadofosveset trisodium were presented as early as 1996 . Phase II and III studies were performed for peripheral arteries in which the prolonged decrease of the blood T1 was used for improved image quality . Early applications reported in the literature included evaluations of aortoiliac occlusive disease and the carotid arteries . Such early clinical reports demonstrated the feasibility of steady-state and dynamic (ie, time-resolved) three-dimensional CE MRA compared to two-dimensional time-of-flight MRA as a reference standard. A recently reported study showed significantly increased image quality with gadofosveset trisodium compared to the low-albumin-binding contrast agent gadopentetate dimeglumine for nondynamic CE MRA at 1.5 T as part of a whole-body imaging approach .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="mr-imaging"><span class="mr-2">MR Imaging</span><a href="#mr-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="qualitative-data-analysis"><span class="mr-2">Qualitative Data Analysis</span><a href="#qualitative-data-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="quantitative-data-analysis"><span class="mr-2">Quantitative Data Analysis</span><a href="#quantitative-data-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonofGadofosvesetTrisodiumandGadobenateDimeglumineDuringTimeResolvedThoracicMRAngiographyat3T/0_1s20S1076633210003132.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonofGadofosvesetTrisodiumandGadobenateDimeglumineDuringTimeResolvedThoracicMRAngiographyat3T/0_1s20S1076633210003132.jpg" alt="Figure 1, Maximum intensity projections (MIP) of selected time frames of time-resolved three-dimensional magnetic resonance angiography performed with gadobenate dimeglumine (top row) and gadofosveset trisodium (bottom row) in coronal orientation. No significant differences in image quality were seen by both readers. Note the inhomogeneous appearance of the gadofosveset images, possibly associated with a stronger T2 effect." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>SNR=mean(ROIavg)SD(ROIsub), SNR</p><p>=</p><p>mean</p><p>(</p><p>ROI</p><p>avg</p><p>)</p><p>SD</p><p>(</p><p>ROI</p><p>sub</p><p>)</p><p>,</p><p>where mean denotes the average signal intensity and SD the standard deviation of all pixels within the ROI. The relative CNR (CNR rel ) was calculated for all vascular ROIs referenced to the surrounding fatty and muscular tissue as</p><p>CNRrel=SNRvasc−SNRrefSNRref, CNR</p><p>rel</p><p>=</p><p>SNR</p><p>vasc</p><p>−</p><p>SNR</p><p>ref</p><p>SNR</p><p>ref</p><p>,</p><p>where SNR vasc is the SNR of the vessel of interest, and SNR ref is calculated for either fat or muscle.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="qualitative-data-analysis-1"><span class="mr-2">Qualitative Data Analysis</span><a href="#qualitative-data-analysis-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Summary of Qualitative Image Grading</p><p>Arteries Aorta First branch Second branch Total SCA 2.7 ± 0.3 (2.5) 3.0 ± 0.0 (3.0) 2.8 ± 0.3 (2.8) 2.8 ± 0.3 (2.8) BPA 2.6 ± 0.4 (2.5) 2.6 ± 0.4 (3.0) 2.5 ± 0.5 (2.5) 2.6 ± 0.4 (2.7) Veins Vena cava First branch Second branch Total SCA 2.9 ± 0.2 (2.5) 2.9 ± 0.2 (3.0) 2.2 ± 0.5 (2.0) 2.6 ± 0.4 (2.5) BPA 2.4 ± 0.5 (2.3) 2.4 ± 0.5 (2.5) 2.1 ± 0.5 (2.0) 2.2 ± 0.5 (2.3) Artifacts Blurring Ghosting Fold-over Total SCA 2.1 ± 0.2 (3.0) 2.9 ± 0.2 (3.0) 2.2 ± 0.4 (2.0) 2.4 ± 0.2 (2.3) BPA 2.0 ± 0.2 (3.0) 3.0 ± 0.0 (3.0) 2.1 ± 0.2 (2.0) 2.3 ± 0.1 (2.3)</p><p>BPA, blood-pool contrast agent (gadofosveset trisodium); SCA, standard contrast agent (gadobenate dimeglumine).</p><p>Data are expressed as mean ± standard deviation (median). No significant differences in image quality between SCA and BPA were observed.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="quantitative-data-analysis-1"><span class="mr-2">Quantitative Data Analysis</span><a href="#quantitative-data-analysis-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonofGadofosvesetTrisodiumandGadobenateDimeglumineDuringTimeResolvedThoracicMRAngiographyat3T/1_1s20S1076633210003132.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonofGadofosvesetTrisodiumandGadobenateDimeglumineDuringTimeResolvedThoracicMRAngiographyat3T/1_1s20S1076633210003132.jpg" alt="Figure 2, Maximum intensity projection (MIP) shortly after maximum arterial contrast enhancement and arterial and venous regions for signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) analysis. For each region, mean relative (rel) CNR fat and CNR muscle are shown for gadobenate dimeglumine (standard contrast agent [SCA]; middle) and gadofosveset trisodium (blood-pool agent [BPA] below). AAo, ascending aorta; AnonV, anonymous vein; BrachTrunc, brachiocephalic trunk; BrachV, brachiocephalic vein, DAo, descending aorta; L subcl A, left subclavian artery; PulmArt, pulmonary artery; R subcl A, right subclavian artery; SVC, superior vena cava. P &lt; .05." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonofGadofosvesetTrisodiumandGadobenateDimeglumineDuringTimeResolvedThoracicMRAngiographyat3T/2_1s20S1076633210003132.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonofGadofosvesetTrisodiumandGadobenateDimeglumineDuringTimeResolvedThoracicMRAngiographyat3T/2_1s20S1076633210003132.jpg" alt="Figure 3, Signal-to-noise ratio (SNR) calculations for five arterial, three venous, and a pulmonary-arterial vascular region. Standard contrast agent (SCA; gadobenate dimeglumine) data demonstrated higher SNR for arteries, whereas blood-pool contrast agent (BPA; gadofosveset trisodium) SNR was superior in veins. SNR differences were not significant for individual vascular regions. Average (avg.) arterial SNR was significantly higher for SCA. AAo, ascending aorta; Anon V, anonymous vein; Brach Trunc, brachiocephalic trunk; Brach V, brachiocephalic vein, DAo, descending aorta; L subcl A, left subclavian artery; Pulm Art, pulmonary-arterial; R subcl A, right subclavian artery; rel, relative; SVC, superior vena cava." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonofGadofosvesetTrisodiumandGadobenateDimeglumineDuringTimeResolvedThoracicMRAngiographyat3T/3_1s20S1076633210003132.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonofGadofosvesetTrisodiumandGadobenateDimeglumineDuringTimeResolvedThoracicMRAngiographyat3T/3_1s20S1076633210003132.jpg" alt="Figure 4, Mean signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) averaged for all evaluated arteries and veins. Significant difference between gadobenate dimeglumine (standard contrast agent [SCA]) and gadofosveset trisodium (blood-pool contrast agent [BPA]) values ( P &lt; .05)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Rohrer M., Bauer H., Mintorovitch J., et. al.: Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: pp. 715-724.</p><li><p>2. Brasch R.C.: Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991; 22: pp. 282-287.</p><li><p>3. Lauffer R.B., Parmelee D.J., Ouellet H.S., et. al.: MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol 1996; 3: pp. S356-S358.</p><li><p>4. Perreault P., Edelman M.A., Baum R.A., et. al.: MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology 2003; 229: pp. 811-820.</p><li><p>5. Rapp J.H., Wolff S.D., Quinn S.F., et. al.: Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography—multicenter comparative phase III study. Radiology 2005; 236: pp. 71-78.</p><li><p>6. Bluemke D.A., Stillman A.E., Bis K.G., et. al.: Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology 2001; 219: pp. 114-122.</p><li><p>7. Klessen C., Hein P.A., Huppertz A., et. al.: First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol 2007; 42: pp. 659-664.</p><li><p>8. Korosec F.R., Frayne R., Grist T.M., et. al.: Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996; 36: pp. 345-351.</p><li><p>9. Lim R.P., Shapiro M., Wang E.Y., et. al.: 3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced bolus-chase MRA and 3D time-of-flight MRA. AJNR Am J Neuroradiol 2008; 29: pp. 1847-1854.</p><li><p>10. Willinek W.A., Hadizadeh D.R., von Falkenhausen M., et. al.: 4D time-resolved MR angiography with keyhole (4D-TRAK): more than 60 times accelerated MRA using a combination of CENTRA, keyhole, and SENSE at 3.0T. J Magn Reson Imaging 2008; 27: pp. 1455-1460.</p><li><p>11. Nielsen Y.W., Eiberg J.P., Logager V.B., et. al.: Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium. Acad Radiol 2009; 16: pp. 654-661.</p><li><p>12. Naehle C.P., Muller A., Willinek W.A., et. al.: First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium. J Magn Reson Imaging 2009; 30: pp. 809-816.</p><li><p>13. Nissen J.C., Attenberger U.I., Fink C., et. al.: Thoracic and abdominal MRA with gadofosveset: influence of injection rate on vessel signal and image quality. Eur Radiol 2009; 19: pp. 1932-1938.</p><li><p>14. Maki J.H., Wang M., Wilson G.J., et. al.: Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents. J Magn Reson Imaging 2009; 30: pp. 1085-1092.</p><li><p>15. Iezzi R., Soulez G., Thurnher S., et. al.: Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium. Eur J Radiol 2009; [Epub ahead of print]</p><li><p>16. Griswold M.A., Jakob P.M., Heidemann R.M., et. al.: Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002; 47: pp. 1202-1210.</p><li><p>17. Pruessmann K.P.: Parallel imaging at high field strength: synergies and joint potential. Top Magn Reson Imaging 2004; 15: pp. 237-244.</p><li><p>18. Reeder S.B., Wintersperger B.J., Dietrich O., et. al.: Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med 2005; 54: pp. 748-754.</p><li><p>19. Laurent S., Elst L.V., Muller R.N.: Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006; 1: pp. 128-137.</p><li><p>20. Cavagna F.M., Marzola P., Dapra M., et. al.: Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts. Invest Radiol 1994; 29: pp. S50-S53.</p><li><p>21. Stalder A.F., Elverfeldt D.V., Paul D., et. al.: Variable echo time imaging: signal characteristics of 1-M gadobutrol contrast agent at 1.5 and 3T. Magn Reson Med 2008; 59: pp. 113-123.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-17/'>Volume 17</a>, <a href='/categories/issue-11/'>Issue 11</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Comparison%20of%20Gadofosveset%20Trisodium%20and%20Gadobenate%20Dimeglumine%20During%20Time-Resolved%20Thoracic%20MR%20Angiography%20at%203T%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcomparison-of-gadofosveset-trisodium-and-gadobenate-dimeglumine-during-time-resolved-thoracic-mr-ang%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Comparison%20of%20Gadofosveset%20Trisodium%20and%20Gadobenate%20Dimeglumine%20During%20Time-Resolved%20Thoracic%20MR%20Angiography%20at%203T%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcomparison-of-gadofosveset-trisodium-and-gadobenate-dimeglumine-during-time-resolved-thoracic-mr-ang%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcomparison-of-gadofosveset-trisodium-and-gadobenate-dimeglumine-during-time-resolved-thoracic-mr-ang%2F&text=Comparison%20of%20Gadofosveset%20Trisodium%20and%20Gadobenate%20Dimeglumine%20During%20Time-Resolved%20Thoracic%20MR%20Angiography%20at%203T%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-s-urvey-of-clinical-research-coordinators-in-the-cooperative-group-setting-of-the-american-college/"><div class="card-body"> <em class="small" data-ts="1288544400" data-df="ll" > Oct 31, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A S urvey of Clinical Research Coordinators in the Cooperative Group Setting of the American College of Radiology Imaging Network (ACRIN)</h3><div class="text-muted small"><p> Rationale and Objectives As one of the newest cooperative groups funded by the National Cancer Institute in 1999, the American College of Radiology Imaging Network (ACRIN) is interested in conduct...</p></div></div></a></div><div class="card"> <a href="/posts/automatic-segmentation-of-cerebrospinal-fluid-white-and-gray-matter-in-unenhanced-computed-tomograp/"><div class="card-body"> <em class="small" data-ts="1288544400" data-df="ll" > Oct 31, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automatic Segmentation of Cerebrospinal Fluid, White and Gray Matter in Unenhanced Computed Tomography Images</h3><div class="text-muted small"><p> Rationale and Objectives Although segmentation algorithms for cerebrospinal fluid (CSF), white matter (WM), and gray matter (GM) on unenhanced computed tomographic (CT) images exist, there is no c...</p></div></div></a></div><div class="card"> <a href="/posts/computer-aided-detection/"><div class="card-body"> <em class="small" data-ts="1288544400" data-df="ll" > Oct 31, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Computer-Aided Detection</h3><div class="text-muted small"><p> Rationale and Objectives Lesion conspicuity is typically highly correlated with visual difficulty for lesion detection, and computer-aided detection (CAD) has been widely used as a “second reader”...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/automatic-segmentation-of-cerebrospinal-fluid-white-and-gray-matter-in-unenhanced-computed-tomograp/" class="btn btn-outline-primary" prompt="Older"><p>Automatic Segmentation of Cerebrospinal Fluid, White and Gray Matter in Unenhanced Computed Tomography Images</p></a> <a href="/posts/computer-aided-detection/" class="btn btn-outline-primary" prompt="Newer"><p>Computer-Aided Detection</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
